GLOBAL FUND TO FIGHT AIDS TUBERCULOSIS AND MALARIA: Form 990, tax year 2022
View the entire original 990 at ProPublica ↗
- Organization
- GLOBAL FUND TO FIGHT AIDS TUBERCULOSIS AND MALARIA (EIN 98-0380092)
- Tax period
- 2022-01-01 to 2022-12-31
- Filed
- 2023-07-13
- IRS object ID
- 202321949349300132
- Schema version
- 2022v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2023-07-13T12:59:14-05:00 | ReturnTs |
| Tax Period End | 2022-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 911194016 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CLARK NUBER PS | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 10900 NE 4TH STREET SUITE 1400 | AddressLine1Txt |
| City | BELLEVUE | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 98004 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2022-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 980380092 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | THE GLOBAL FUND TO FIGHT AIDS | BusinessNameLine1Txt |
| Business Name Line2 | TUBERCULOSIS AND MALARIA | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | GLOB | BusinessNameControlTxt |
| Foreign Phone | 41587911700 | ForeignPhoneNum |
Foreign Address ForeignAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | CHEMIN DU POMMIER 40 | AddressLine1Txt |
| City | CH GENEVA | CityNm |
| Country | SZ | CountryCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | ADDA FAYE | PersonNm |
| Person Title | CHIEF FINANCIAL OFFICER | PersonTitleTxt |
| Foreign Phone | 41587911700 | ForeignPhoneNum |
| Signature | 2023-07-07 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | ADDA | PersonFirstNm |
| Person Last | FAYE | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 888008888 | SSN |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | 0 | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | JENNIFER BECKER HARRIS | PreparerPersonNm |
| PTIN | P00183358 | PTIN |
| Phone | 4254544919 | PhoneNum |
| Preparation | 2023-07-07 | PreparationDt |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 2 | TrustedCustomerCd |
| Authentication Assurance Level | AAL1 | AuthenticationAssuranceLevelCd |
| Identity Assurance Level | IAL1 | IdentityAssuranceLevelCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2022 | TaxYr |
| Build TS | 2023-04-26 12:10:37Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | PETER SANDS | PrincipalOfficerNm |
Foreign Address ForeignAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | CHEMIN DU POMMIER 40 | AddressLine1Txt |
| City | CH GENEVA | CityNm |
| Country | SZ | CountryCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $6,964,263,943 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.THEGLOBALFUND.ORG | WebsiteAddressTxt |
| Type Of Organization Other | Yes (X) | TypeOfOrganizationOtherInd |
| Other Organization Dsc | SF SWISS FOUNDATION | OtherOrganizationDsc |
| Formation | 2002 | FormationYr |
| Legal Domicile Country | SZ | LegalDomicileCountryCd |
| Activity Or Mission | THE PURPOSE OF THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND) IS TO ATTRACT, LEVERAGE AND INVEST RESOURCES TO END THE EPIDEMICS OF HIV/AIDS, TUBERCULOSIS AND MALARIA TO SUPPORT ATTAINMENT OF THE SUSTAINABLE DEVELOPMENT GOALS ESTABLISHED BY THE UNITED NATIONS. | ActivityOrMissionDesc |
| Voting Members Governing Body | 20 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 20 | VotingMembersIndependentCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Total Volunteers | 0 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $3,815,758,210 | PYContributionsGrantsAmt |
| CY Contributions Grants | $6,866,747,317 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $76,377,069 | PYInvestmentIncomeAmt |
| CY Investment Income | $97,516,626 | CYInvestmentIncomeAmt |
| PY Other Revenue | $0 | PYOtherRevenueAmt |
| CY Other Revenue | $0 | CYOtherRevenueAmt |
| PY Total Revenue | $3,892,135,279 | PYTotalRevenueAmt |
| CY Total Revenue | $6,964,263,943 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $6,784,583,315 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $4,652,603,732 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $190,472,636 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $214,003,713 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $15,377,233 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $153,746,800 | PYOtherExpensesAmt |
| CY Other Expenses | $187,854,156 | CYOtherExpensesAmt |
| PY Total Expenses | $7,128,802,751 | PYTotalExpensesAmt |
| CY Total Expenses | $5,054,461,601 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$3,236,667,472 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $1,909,802,342 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $7,217,506,992 | TotalAssetsBOYAmt |
| Total Assets EOY | $8,267,999,439 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $4,030,271,876 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $3,660,917,671 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $3,187,235,116 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $4,607,081,768 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | THE PURPOSE OF THE GLOBAL FUND IS TO ATTRACT, LEVERAGE AND INVEST RESOURCES TO END THE EPIDEMICS OF HIV/AIDS, TUBERCULOSIS AND MALARIA TO SUPPORT ATTAINMENT OF THE SUSTAINABLE DEVELOPMENT GOALS ESTABLISHED BY THE UNITED NATIONS. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $4,874,027,744 | ExpenseAmt |
| Grant | $4,546,887,644 | GrantAmt |
| Desc | PROVIDING GRANTS TO LOCALLY-DEVELOPED PROGRAMS FOR THE PREVENTION, TREATMENT OR CARE OF HIV/AIDS, TUBERCULOSIS AND MALARIA AND FOR HEALTH SYSTEM STRENGTHENING. FOLLOWING THE BOARD DECISION ON APRIL 9, 2020, THE GLOBAL FUND LAUNCHED AN APPEAL TO RAISE ADDITIONAL FUNDING FOR COVID-19 EMERGENCY RESPONSE AND CREATED THE COVID-19 RESPONSE MECHANISM ("C19RM"), WHICH WAS EXTENDED SUCCESSIVELY THROUGH FURTHER BOARD DECISIONS IN SEC. 101, INCLUDING THE AWARD OF C19RM FUNDS THROUGH 30 JUNE 2023. DURING 2022, THE BOARD APPROVED AN ADDITIONAL EXTENSION OF C19RM, AND ENABLING IMPLEMENTATION OF C19RM FUNDS THROUGH 31 DECEMBER 2025. (CONTINUED ON SCHEDULE O)DONOR CONTRIBUTIONS RECOGNIZED IN 2022 IN THE STATEMENT OF INCOME INCLUDE USD 2.3 BILLION (2021: USD 1.8 BILLION) RECEIVED IN RESPONSE TO THIS APPEAL AND ALLOCATED BY THE BOARD DECISION TO C19RM, IN ACCORDANCE WITH PLEDGES RECEIVED THROUGH 30 SEPTEMBER 2022, FOLLOW THE COMPREHENSIVE FUNDING POLICY. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $105,716,088 | ExpenseAmt |
| Grant | $105,716,088 | GrantAmt |
| Desc | STRATEGIC INITIATIVE PROJECTS-STRATEGIC INITIATIVE PROJECTS FACILITATE GRANT IMPLEMENTATION BY FINANCING TECHNICAL ASSISTANCE, CAPACITY DEVELOPMENT, ALTERNATIVE FUNDING MECHANISMS AND OTHER STRATEGIC PRIORITIES. THEY ARE IMPLEMENTED THROUGH PROJECT PARTNERS LIKE LOCAL GOVERNMENT AGENCIES, INTERNATIONAL ORGANIZATIONS AND PRIVATE FOUNDATIONS. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $4,979,743,832 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | 0 | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | Yes (1) | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | 0 | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| Info In Schedule O Part V | Yes (X) | InfoInScheduleOPartVInd |
| IRP Document | 0 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Employee | 0 | EmployeeCnt |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | Yes (1) | ForeignFinancialAccountInd |
| Foreign Country | SZ | ForeignCountryCd |
| Foreign Country | FR | ForeignCountryCd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 20 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 20 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | Yes (1) | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | Yes (1) | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | 0 | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ADDA FAYE | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 4158791700 | PhoneNum |
Foreign Address ForeignAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | CHEMIN DU POMMIER 40 | AddressLine1Txt |
| City | GENEVA | CityNm |
| Country | SZ | CountryCd |
| Foreign Postal | CH-1218 | ForeignPostalCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (56 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd |
|---|---|---|---|---|---|---|---|---|---|
| JOSHUA TABAH | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| JAVIER HOURCADE BELLOCQ | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| ERIKA CASTELLANOS | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| BEATRIJS STIKKERS | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| ROBIN MONTGOMERY | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| DR CAROLYN GOMES | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| SUSAN MOCHACHE | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| MISO PEJKOVIC | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| DR MOHSEN ASADI-LARI | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| DR GABRIELA FESUS | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| ANNE-CLAIRE AMPROU | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| AMB STEPHANIE SEYDOUX | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| TANIA VORWERK | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| BIRGIT PICKEL | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| KEICHII HARA | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| ALEJANDRA ACUA NAVARRO | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| DR MIRTA ROSES PERIAGO | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| MAIRE MATTHEWS | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| KIERAN DALY | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| DR RAJENDRA JOSHI | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| KUNZANG WANGDI | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| BETH ARTHY | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| AMB JOHN NKENGASONG | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| DR ANGELI ACHREKAR | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| DR JEAN-JACQUES MBUNGANI | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| PROF PASCAL NIAMBA | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| FIU WILLIAME-IGARA | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| SHERWIN CHARLES | |||||||||
| BOARD MEMBER | 10.00 | Yes (X) | $0 | $0 | $0 | ||||
| PETER ALEXANDER SANDS | |||||||||
| EXECUTIVE DIRECTOR | 50.00 | $410,843 | $0 | $95,798 | Yes (X) | ||||
| ADDA FAYE | |||||||||
| CHIEF FINANCIAL OFFICER | 50.00 | $359,232 | $0 | $78,843 | Yes (X) | ||||
| DR DONALD KABERUKA | |||||||||
| CHAIR | 10.00 | $40,000 | $0 | $0 | Yes (X) | ||||
| LADY ROSLYN MORAUTA | |||||||||
| VICE-CHAIR | 10.00 | $30,000 | $0 | $0 | Yes (X) | ||||
| MARK ELDON EDINGTON | |||||||||
| HEAD, GRANT MANAGEMENT DIVISION | 50.00 | $485,372 | $0 | $63,808 | Yes (X) | ||||
| MARIA PETROVA KIROVA | |||||||||
| HEAD, GRANT MANAGEMENT DEPARTMENT | 50.00 | $438,263 | $0 | $62,761 | Yes (X) | ||||
| MICHAEL WAINFORD JOHNSON | |||||||||
| CHIEF INFORMATION OFFICER | 50.00 | $415,628 | $0 | $63,968 | Yes (X) | ||||
| MICHAEL DAVID BYRNE | |||||||||
| HEAD, TECH ADVISORY & PARTNERSHIPS | 50.00 | $396,707 | $0 | $57,865 | Yes (X) | ||||
| ABIGAIL MORELAND | |||||||||
| HEAD, GRANT MANAGEMENT DEPARTMENT | 50.00 | $392,861 | $0 | $61,840 | Yes (X) | ||||
| HARLEY FELDBAUM | |||||||||
| HEAD STRATEGY AND POLICY HUB | 50.00 | $387,162 | $0 | $57,226 | Yes (X) | ||||
| TRACY STAINES | |||||||||
| INSPECTOR GENERAL | 50.00 | $379,593 | $0 | $75,474 | Yes (X) | ||||
| RAHUL SINGHAL | |||||||||
| CHIEF RISK OFFICER | 50.00 | $374,487 | $0 | $63,655 | Yes (X) | ||||
| FRANCOISE VANNI CHACIN SOLANO | |||||||||
| HEAD, EXTERNAL RELATIONS AND COMMS | 50.00 | $355,501 | $0 | $67,653 | Yes (X) | ||||
| SUSIE RHEE | |||||||||
| GENERAL COUNSEL | 50.00 | $353,495 | $0 | $52,227 | Yes (X) | ||||
| ANNELISE HIRSCHMANN | |||||||||
| HEAD, GRANT MANAGEMENT DEPARTMENT | 50.00 | $320,452 | $0 | $46,646 | Yes (X) | ||||
| MARIJKE WIJNROKS | |||||||||
| CHIEF OF STAFF | 50.00 | $306,415 | $0 | $57,538 | Yes (X) | ||||
| URBAN JOHANNES WEBER | |||||||||
| HEAD, GRANT MANAGEMENT DEPARTMENT | 50.00 | $279,312 | $0 | $57,213 | Yes (X) | ||||
| HUI YANG | |||||||||
| CHIEF PROCUREMENT OFFICER | 50.00 | $268,320 | $0 | $53,188 | Yes (X) | ||||
| LINDEN RIDLEY MORRISON | |||||||||
| HEAD, GRANT MANAGEMENT DEPARTMENT | 50.00 | $261,092 | $0 | $50,585 | Yes (X) | ||||
| CATY FALL | |||||||||
| REGIONAL MANAGER, CENTRAL AFRICA | 50.00 | $259,073 | $0 | $65,824 | Yes (X) | ||||
| CYNTHIA SIMANGELA MWASE | |||||||||
| HEAD, GRANT MANAGEMENT DEPARTMENT | 50.00 | $245,704 | $0 | $56,532 | Yes (X) | ||||
| MARASI MWENCHA | |||||||||
| SENIOR MANAGER, SUPPLY CHAIN | 50.00 | $462,688 | $0 | $44,432 | Yes (X) | ||||
| GEORGE SHAKARISHVILI | |||||||||
| SENIOR MANAGER, STRATEGY | 50.00 | $450,253 | $0 | $18,052 | Yes (X) | ||||
| SCOTT JAY FILLER | |||||||||
| HEAD, MALARIA DISEASE ADVISOR | 50.00 | $354,478 | $0 | $49,604 | Yes (X) | ||||
| NOAH AMADOR ZAHROBSKY | |||||||||
| SENIOR FUND PORTFOLIO MANAGER | 50.00 | $350,054 | $0 | $45,148 | Yes (X) | ||||
| JOHN ANDREW FAIRHURST | |||||||||
| HEAD, PRIVATE SECTOR ENGAGEMENTS | 50.00 | $326,482 | $0 | $57,829 | Yes (X) | ||||
| MARK EDWARD SAALFELD | |||||||||
| FORMER KEY EMPLOYEE | 50.00 | $252,226 | $0 | $40,563 | Yes (X) | ||||
| FADY ZEIDAN | |||||||||
| FORMER KEY EMPLOYEE | 50.00 | $224,905 | $0 | $33,083 | Yes (X) | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $9,180,598 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $1,477,355 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 1016 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | Yes (1) | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt | CityContractorAddress/ForeignAddress/CityNm | CountryContractorAddress/ForeignAddress/CountryCd | Foreign PostalContractorAddress/ForeignAddress/ForeignPostalCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| PRICEWATERHOUSECOOPERS | |||||
| AVE GUISEPPE MOTTA 50 | GENEVA | SZ | 1211 | LOCAL FUND AGENTS AND MANAGEMENT CONSULT | $34,293,497 |
| WORLD HEALTH ORGANIZATION | |||||
| 20 AVENUE APPIA | GENEVA | SZ | 1211 | STRATEGIC INITIATIVES PROJECTS | $20,484,872 |
| IDA FOUNDATION | |||||
| SLOCHTERWEG 35 | AMSTERDAM | NL | 1027 AA | STRATEGIC INITIATIVES PROJECTS | $14,798,171 |
| COGNIZANT WORLDWIDE LIMITED | |||||
| 1 KINGDOM STREET | LONDON | UK | W2 6BD | IT TECHNICAL & STRATEGIC BUS. PARTNERS | $9,927,471 |
| SWISS CENTRE FOR INT'L HEALTH SWISS TPH | |||||
| SOCINSTRASSE 57 PO BOX | BASEL | SZ | CH-4002 | LOCAL FUND AGENTS | $7,229,165 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 283 | CntrctRcvdGreaterThan100KCnt |
| Government Grants | $6,646,234,029 | GovernmentGrantsAmt |
| All Other Contributions | $220,513,288 | AllOtherContributionsAmt |
| Total Contributions | $6,866,747,317 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $97,516,626 | TotalRevenueColumnAmt |
| Exclusion | $97,516,626 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $6,964,263,943 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $97,516,626 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,652,603,732 | TotalAmt |
| Program Services | $4,652,603,732 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,948,152 | TotalAmt |
| Program Services | $6,755,929 | ProgramServicesAmt |
| Management And General | $794,815 | ManagementAndGeneralAmt |
| Fundraising | $397,408 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $179,807,383 | TotalAmt |
| Program Services | $152,836,276 | ProgramServicesAmt |
| Management And General | $17,980,738 | ManagementAndGeneralAmt |
| Fundraising | $8,990,369 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $23,080,821 | TotalAmt |
| Program Services | $19,618,698 | ProgramServicesAmt |
| Management And General | $2,308,082 | ManagementAndGeneralAmt |
| Fundraising | $1,154,041 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,167,357 | TotalAmt |
| Program Services | $2,692,253 | ProgramServicesAmt |
| Management And General | $316,736 | ManagementAndGeneralAmt |
| Fundraising | $158,368 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $38,611,519 | TotalAmt |
| Program Services | $32,819,791 | ProgramServicesAmt |
| Management And General | $3,861,152 | ManagementAndGeneralAmt |
| Fundraising | $1,930,576 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $231,918 | TotalAmt |
| Program Services | $197,130 | ProgramServicesAmt |
| Management And General | $23,192 | ManagementAndGeneralAmt |
| Fundraising | $11,596 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $17,000 | TotalAmt |
| Program Services | $14,450 | ProgramServicesAmt |
| Management And General | $1,700 | ManagementAndGeneralAmt |
| Fundraising | $850 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,114,002 | TotalAmt |
| Management And General | $2,114,002 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $878,245 | TotalAmt |
| Program Services | $746,508 | ProgramServicesAmt |
| Management And General | $87,825 | ManagementAndGeneralAmt |
| Fundraising | $43,912 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $22,389,148 | TotalAmt |
| Program Services | $19,030,776 | ProgramServicesAmt |
| Management And General | $2,238,915 | ManagementAndGeneralAmt |
| Fundraising | $1,119,457 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,783,221 | TotalAmt |
| Program Services | $4,065,738 | ProgramServicesAmt |
| Management And General | $478,322 | ManagementAndGeneralAmt |
| Fundraising | $239,161 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $13,475,477 | TotalAmt |
| Program Services | $11,454,155 | ProgramServicesAmt |
| Management And General | $1,347,548 | ManagementAndGeneralAmt |
| Fundraising | $673,774 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,742,216 | TotalAmt |
| Program Services | $4,880,883 | ProgramServicesAmt |
| Management And General | $574,222 | ManagementAndGeneralAmt |
| Fundraising | $287,111 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,915,225 | TotalAmt |
| Program Services | $4,177,941 | ProgramServicesAmt |
| Management And General | $491,523 | ManagementAndGeneralAmt |
| Fundraising | $245,761 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $682,597 | TotalAmt |
| Program Services | $580,207 | ProgramServicesAmt |
| Management And General | $68,260 | ManagementAndGeneralAmt |
| Fundraising | $34,130 | FundraisingAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| LOCAL FUND AGENTS FEES | $56,973,759 | $56,973,759 | ||
| CCM FUNDING | $7,696,437 | $7,696,437 | ||
| COMMUNICATIONS | $1,814,387 | $1,542,229 | $181,439 | $90,719 |
| BOARD CONSTITUENCY FUND | $1,056,940 | $1,056,940 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $26,472,065 | TotalAmt |
| Management And General | $26,472,065 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,054,461,601 | TotalAmt |
| Program Services | $4,979,743,832 | ProgramServicesAmt |
| Management And General | $59,340,536 | ManagementAndGeneralAmt |
| Fundraising | $15,377,233 | FundraisingAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $217,804,051 | BOYAmt |
| EOY | $135,154,192 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,429,070,922 | BOYAmt |
| EOY | $2,004,025,219 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $43,538,742 | BOYAmt |
| EOY | $39,739,869 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $90,020,404 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $48,635,193 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $47,626,818 | BOYAmt |
| EOY | $41,385,211 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,418,339,772 | BOYAmt |
| EOY | $5,977,706,067 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,484,831 | BOYAmt |
| EOY | $559,587 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $58,641,856 | BOYAmt |
| EOY | $69,429,294 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,217,506,992 | BOYAmt |
| EOY | $8,267,999,439 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $71,240,782 | BOYAmt |
| EOY | $66,804,862 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,655,040,890 | BOYAmt |
| EOY | $3,043,269,077 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $303,990,204 | BOYAmt |
| EOY | $550,843,732 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,030,271,876 | BOYAmt |
| EOY | $3,660,917,671 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,120,736,660 | BOYAmt |
| EOY | $4,556,450,858 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $66,498,456 | BOYAmt |
| EOY | $50,630,910 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,187,235,116 | BOYAmt |
| EOY | $4,607,081,768 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,217,506,992 | BOYAmt |
| EOY | $8,267,999,439 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $1,909,802,342 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$168,000,000 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | -$321,955,690 | OtherChangesInNetAssetsAmt |
| Info In Schedule O Part XII | Yes (X) | InfoInScheduleOPartXIIInd |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $2,057,479,604 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $3,804,874,587 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $6,837,636,519 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $3,815,758,210 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $6,866,747,317 | CurrentTaxYearAmt |
| Total | $23,382,496,237 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $2,057,479,604 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $3,804,874,587 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $6,837,636,519 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $3,815,758,210 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $6,866,747,317 | CurrentTaxYearAmt |
| Total | $23,382,496,237 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $501,748,715 | SubstantialContributorsTotAmt |
| Public Support Total170 | $22,880,747,522 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $24,378,375 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $149,819,587 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $114,287,013 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $76,377,069 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $97,516,626 | CurrentTaxYearAmt |
| Total | $462,378,670 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $23,844,874,907 | TotalSupportAmt |
| Public Support CY170 | 0.95960 | PublicSupportCY170Pct |
| Public Support PY170 | 0.94900 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $71,720,775 | OtherCostOrOtherBasisAmt |
| Depreciation | $34,728,353 | DepreciationAmt |
| Book Value | $36,992,422 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $106,074 | OtherCostOrOtherBasisAmt |
| Depreciation | $1,768 | DepreciationAmt |
| Book Value | $104,306 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $18,193,555 | OtherCostOrOtherBasisAmt |
| Depreciation | $13,905,072 | DepreciationAmt |
| Book Value | $4,288,483 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $41,385,211 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (3 entries)
| DescDesc | AmtAmt |
|---|---|
| EMPLOYEE BENEFIT LIABILITIES | $244,311,464 |
| FORWARD CURRENCY CONTRACTS AT FAIR VALUE | $268,249,222 |
| LEASE LIABILITY | $38,283,046 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $550,843,732 | TotalLiabilityAmt |
| Total Rev Etc Audited Fincl Stmt | $6,473,436,405 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$168,000,000 | NetUnrealizedGainsInvstAmt |
| Other Revenue | -$326,356,030 | OtherRevenueAmt |
| Revenue Not Reported | -$494,356,030 | RevenueNotReportedAmt |
| Revenue Subtotal | $6,967,792,435 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $2,114,002 | InvestmentExpensesNotIncldAmt |
| Other Revenues Not Included | -$5,642,494 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | -$3,528,492 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $6,964,263,943 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $5,082,024,758 | TotExpnsEtcAuditedFinclStmtAmt |
| Other Expenses Included | $29,677,159 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $29,677,159 | ExpensesNotReportedAmt |
| Expenses Subtotal | $5,052,347,599 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $2,114,002 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $2,114,002 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $5,054,461,601 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART XI, LINE 2D - OTHER ADJUSTMENTS: | UNREALIZED GAIN/LOSS ON CONTRIBUTIONS -326,356,030. |
| PART XI, LINE 4B - OTHER ADJUSTMENTS: | RECLASSIFICATION OF NET FOREIGN EXCHANGE GAIN/LOSS -4,556,042. DISCOUNTING -1,086,452. |
| PART XII, LINE 2D - OTHER ADJUSTMENTS: | RECOVERED GRANTS NETTED WITH GRANT EXPENSES -3,142,583. IAS 19 DBO ADJUSTMENT 25,242,240. UNREALIZED GAIN/LOSS ON GRANTS & OPER EXPENSES 2,486,159. RECLASSIFICATION OF NET FOREIGN EXCHANGE GAIN/LOSS 4,556,042. REIMBURSEMENT OF PRIOR YEAR SUPPLY EXPENSE -551,151. DISCOUNTING 1,086,452. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | 0 | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (19 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Region Total ExpendituresRegionTotalExpendituresAmt | Specific Services ProvidedSpecificServicesProvidedTxt |
|---|---|---|---|---|---|
| CENTRAL AMERICA AND THE CARIBBEAN - ANTIGUA & BARBUDA, ARUBA, BAHAMAS, | 0 | 0 | GRANTS TO RECIPIENTS IN THE REGION | $107,371,028 | |
| EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, | 0 | 0 | GRANTS TO RECIPIENTS IN THE REGION | $526,906,071 | |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 0 | 0 | GRANTS TO RECIPIENTS IN THE REGION | $9,001,211 | |
| MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, | 0 | 0 | GRANTS TO RECIPIENTS IN THE REGION | $30,509,555 | |
| RUSSIA AND NEIGHBORING STATES - ARMENIA, AZERBAIJAN, BELARUS, | 0 | 0 | GRANTS TO RECIPIENTS IN THE REGION | $168,294,934 | |
| SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, | 0 | 0 | GRANTS TO RECIPIENTS IN THE REGION | $61,437,665 | |
| SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, | 0 | 0 | GRANTS TO RECIPIENTS IN THE REGION | $346,523,958 | |
| SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO, | 0 | 0 | GRANTS TO RECIPIENTS IN THE REGION | $3,331,443,944 | |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 0 | 0 | STRATEGIC INITIATIVE PROJECTS | $105,716,088 | |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 1 | 1075 | OPERATING AND FUNDRAISING EXPENSES OF THE SECRETARIAT LESS OF LFA COSTS | $239,168,022 | |
| EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, | 0 | 0 | PROGRAM SERVICES | $4,413,180 | LOCAL FUND AGENT FEES |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 0 | 0 | PROGRAM SERVICES | $1,493,987 | LOCAL FUND AGENT FEES |
| MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, | 0 | 0 | PROGRAM SERVICES | $1,377,186 | LOCAL FUND AGENT FEES |
| RUSSIA AND NEIGHBORING STATES - ARMENIA, AZERBIJAN, BELARUS, | 0 | 0 | PROGRAM SERVICES | $2,461,607 | LOCAL FUND AGENT FEES |
| SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, | 0 | 0 | PROGRAM SERVICES | $3,238,702 | LOCAL FUND AGENT FEES |
| SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, | 0 | 0 | PROGRAM SERVICES | $4,958,530 | LOCAL FUND AGENT FEES |
| SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO, | 0 | 0 | PROGRAM SERVICES | $39,030,567 | LOCAL FUND AGENT FEES |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 0 | 0 | CASH BALANCE HELD IN COMMERCIAL BANKS | $135,154,192 | |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 0 | 0 | PROVIDENT FUND INVESTMENTS | $234,509,784 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 1 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 1075 | ContinuationTotalEmployeeCnt |
| Total Office | 1 | TotalOfficeCnt |
| Total Employee | 1075 | TotalEmployeeCnt |
| Subtotal Spent | $4,581,488,366 | SubtotalSpentAmt |
| Continuation Spent | $771,521,845 | ContinuationSpentAmt |
| Total Spent | $5,353,010,211 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (257 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt | Non Cash AssistanceNonCashAssistanceAmt |
|---|---|---|---|---|
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF HIV/AIDS | $761,113 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF MALARIA | $288,491 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF OTHER | $8,374,412 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF MALARIA | $3,200,756 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF HIV/AIDS | $814,578 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF HIV/AIDS | $5,178,391 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF HIV/AIDS | $800,095 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF MALARIA | $3,763,026 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF TUBERCULOSIS | $3,977,891 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF HIV/AIDS | $8,955,631 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF HIV/AIDS | $14,693,316 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF TUBERCULOSIS | $251,064 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF HIV/AIDS | $5,600,246 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF HIV/AIDS | $149,823 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF MALARIA | $26,103,012 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF HIV/AIDS | $25,647,923 | WIRE TRANSFER | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | TREATMENT AND PREVENTION OF TUBERCULOSIS | $43,771 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $7,119,414 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $25,386,064 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF OTHER | $354,596 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $18,744,996 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $426,895 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF MALARIA | $12,020,038 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF TUBERCULOSIS | $116,792,435 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $16,117 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $7,909,958 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF TUBERCULOSIS | $4,402,135 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF TUBERCULOSIS | $22,210,936 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $1,897,477 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $5,599,670 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $3,680,413 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF MALARIA | $459,973 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF TUBERCULOSIS | $1,133,446 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $3,152,116 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF MALARIA | $7,907,743 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF TUBERCULOSIS | $55,697,114 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $5,648,679 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF MALARIA | $983,997 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $13,393,415 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $14,213,277 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF TUBERCULOSIS | $4,166,743 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF MALARIA | $852,069 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF TUBERCULOSIS | $470,027 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF MALARIA | $11,436,267 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF OTHER | $12,480,073 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $4,412,138 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF MALARIA | $810,207 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $14,993,913 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF MALARIA | $89,595,816 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF TUBERCULOSIS | $13,271,010 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $4,657,770 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF TUBERCULOSIS | $13,832,348 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $2,844,627 | WIRE TRANSFER | $0 |
| EAST ASIA AND THE PACIFIC | TREATMENT AND PREVENTION OF HIV/AIDS | $26,145,464 | WIRE TRANSFER | $0 |
| EUROPE (INCLUDING ICELAND AND GREENLAND) | TREATMENT AND PREVENTION OF HIV/AIDS | $140,415 | WIRE TRANSFER | $0 |
| EUROPE (INCLUDING ICELAND AND GREENLAND) | TREATMENT AND PREVENTION OF HIV/AIDS | $1,973,292 | WIRE TRANSFER | $0 |
| EUROPE (INCLUDING ICELAND AND GREENLAND) | TREATMENT AND PREVENTION OF HIV/AIDS | $635,396 | WIRE TRANSFER | $0 |
| EUROPE (INCLUDING ICELAND AND GREENLAND) | TREATMENT AND PREVENTION OF HIV/AIDS | $825,603 | WIRE TRANSFER | $0 |
| EUROPE (INCLUDING ICELAND AND GREENLAND) | TREATMENT AND PREVENTION OF TUBERCULOSIS | $5,452,640 | WIRE TRANSFER | $0 |
| MIDDLE EAST AND NORTH AFRICA | TREATMENT AND PREVENTION OF OTHER | $12,982,649 | WIRE TRANSFER | $0 |
| MIDDLE EAST AND NORTH AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $44,481 | WIRE TRANSFER | $0 |
| MIDDLE EAST AND NORTH AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $804,977 | WIRE TRANSFER | $0 |
| MIDDLE EAST AND NORTH AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $2,952,016 | WIRE TRANSFER | $0 |
| MIDDLE EAST AND NORTH AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $12,637,502 | WIRE TRANSFER | $0 |
| MIDDLE EAST AND NORTH AFRICA | TREATMENT AND PREVENTION OF OTHER | $1,115,577 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF HIV/AIDS | $13,548,043 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF HIV/AIDS | $15,877,354 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF HIV/AIDS | $902,804 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF HIV/AIDS | $3,540,021 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF HIV/AIDS | $4,813,837 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF HIV/AIDS | $9,170,043 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF TUBERCULOSIS | $1,798,621 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF HIV/AIDS | $8,757,372 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF HIV/AIDS | $18,414,689 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF TUBERCULOSIS | $8,291,522 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF HIV/AIDS | $6,051,286 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF HIV/AIDS | $28,165,423 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF HIV/AIDS | $15,000,000 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF HIV/AIDS | $37,743,666 | WIRE TRANSFER | $0 |
| RUSSIA AND NEIGHBORING STATES | TREATMENT AND PREVENTION OF TUBERCULOSIS | $770,646 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $648,956 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF HIV/AIDS | $31,211 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF HIV/AIDS | $6,020,884 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF HIV/AIDS | $535,841 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF HIV/AIDS | $8,835,530 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF HIV/AIDS | $9,506,095 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF HIV/AIDS | $932,051 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF MALARIA | $1,110,265 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF HIV/AIDS | $151,055 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF MALARIA | $977,991 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF HIV/AIDS | $207,755 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF HIV/AIDS | $1,228,015 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $2,487,610 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF HIV/AIDS | $5,850,000 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $394,194 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF HIV/AIDS | $13,332,322 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $761,932 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF HIV/AIDS | $150,000 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF MALARIA | $5,898,046 | WIRE TRANSFER | $0 |
| SOUTH AMERICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $2,381,293 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF MALARIA | $5,190,842 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $20,514,550 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF HIV/AIDS | $33,047,616 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $56,715,490 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF HIV/AIDS | $734,232 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF MALARIA | $13,246,106 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $31,301,505 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $11,657,153 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF HIV/AIDS | $9,235,991 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF MALARIA | $10,392,352 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF HIV/AIDS | $3,199,560 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $3,212,499 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $11,212,197 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF HIV/AIDS | $564,311 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF MALARIA | $749,939 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $1,401,167 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF HIV/AIDS | $1,658,991 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF MALARIA | $367,842 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF MALARIA | $20,705,858 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF HIV/AIDS | $5,745,851 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $98,363,790 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF HIV/AIDS | $20,632,786 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF MALARIA | $1,079,675 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $5,514,214 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF MALARIA | $328,804 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF HIV/AIDS | $16,068,933 | WIRE TRANSFER | $0 |
| SOUTH ASIA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $7,497,799 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $218,924 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $58,714,084 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $2,238,173 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $12,363,777 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $9,785,761 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $662,068 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $11,544,882 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $4,062,504 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $49,651,435 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $924,410 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $14,097,272 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $232,397,845 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $5,598,129 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $5,617,494 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $2,058,194 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $21,562,271 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $7,030,032 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $27,515,787 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $5,746,073 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $5,575,679 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $7,205,660 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $820,343 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $6,387,935 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $22,220,816 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $25,441,706 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $14,645,571 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $24,938,368 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $15,972,723 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $49,230,759 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $2,624,294 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $4,272,126 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $2,746,479 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $11,356,419 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $32,926,293 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $2,588,593 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $15,328,163 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $9,858,046 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $3,151,091 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $93,648,125 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $95,175,647 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $26,938,600 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $20,543,694 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $156,997,097 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $102,534,857 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $2,890,301 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $63,660,774 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $11,918,148 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $11,938,360 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $5,648,996 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $1,872,312 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $149,787 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $36,532,280 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $91,523,447 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $3,951,152 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $42,229,356 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $21,255,143 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $7,395,295 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $116,457,995 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $3,269,772 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $8,764,381 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $4,740,960 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $49,630,131 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $9,733,492 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $2,079,006 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $1,924,789 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $6,834,019 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $6,558,410 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $1,635,718 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $15,745,919 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $38,222,378 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $22,263,508 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $5,788,606 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $2,123,685 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $3,363,796 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $29,980,970 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $25,838,943 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $120,957 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $70,852,221 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $13,394,682 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $3,888,083 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $12,692,344 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $3,401,417 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $22,174,476 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $19,601,953 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $3,100,422 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $16,893,474 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $5,169,656 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $84,431,923 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $121,542,055 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $3,692,463 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $1,500,496 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $16,756,502 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $25,704,339 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $14,821,769 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $47,630,383 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $5,280,225 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $41,915,188 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $18,050,533 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $98,702 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF OTHER | $2,093,318 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $639,529 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $996,458 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $13,769,508 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $27,441,771 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $842,628 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $38,820,264 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $1,680,831 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $29,572,296 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $9,645,989 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $355,155 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $181,854,983 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $11,257,961 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $4,190,809 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $8,394,792 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $112,154,240 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $6,979,915 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $1,232,050 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $53,444,381 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $8,981,633 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $19,669,785 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $4,276,067 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $4,766,412 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $36,081,511 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $211,522,368 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $62,374,136 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $4,123,074 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $1,392,681 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF HIV/AIDS | $2,262,732 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF MALARIA | $68,459,392 | WIRE TRANSFER | $0 |
| SUB-SAHARAN AFRICA | TREATMENT AND PREVENTION OF TUBERCULOSIS | $10,491,168 | WIRE TRANSFER | $0 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 257 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | Yes (1) | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 2: | ALL GRANT FUNDS OF THE GLOBAL FUND ARE DISBURSED OUTSIDE THE US. THE GLOBAL FUND FOLLOWS PERFORMANCE BASED FUNDING WHEREIN FURTHER DISBURSEMENTS TO THE PRINCIPAL RECIPIENT ARE DETERMINED BASED ON THE PROJECT REPORTS AND CASH REQUESTS THAT ARE REVIEWED AND APPROVED BY THE FUND PORTFOLIO STAFF BASED ON THE RECOMMENDATION OF THE LOCAL FUND AGENTS (LFA). DEPENDING UPON THE RISK ASSESSMENT AND PROJECT STATUS, LFA MAY BE REQUESTED TO UNDERTAKE SPECIFIC IN-COUNTRY MONITORING ACTIVITIES. |
| PART I, LINE 3: | MODIFIED IFRS IS USED AS THE METHOD OF ACCOUNTING FOR THE FOREIGN EXPENDITURES. THE MODIFICATION INCLUDES FOREIGN CURRENCY GAIN OF $4,556,042 ON GRANTS, WHICH HAS NOT BEEN NETTED AGAINST FOREIGN EXPENDITURES AND GRANTS REPORTED ON SCHEDULE F, PART I AND PART II. SEE NOTE 5.7 TO THE 2022 ANNUAL FINANCIAL STATEMENTS FOR MORE DETAILS ON THE NET FOREIGN EXCHANGE RESULTS. |
| PART III ACCOUNTING METHOD: | |
| SCHEDULE F, PART I, LINE 3, COLUMN (C), NUMBER OF EMPLOYEES: | THE NUMBER REPRESENTS THE NUMBER OF PERSONNEL EMPLOYED BY THE GLOBAL FUND AND IT DOES NOT INCLUDE THE NUMBER OF INDIVIDUAL CONTRACTORS. |
| SCHEDULE F, PART I, LINE 3, COLUMN (A) AND PART II, COLUMN (A): | THE GLOBAL FUND GRANT RECIPIENTS HAVE BEEN MAPPED IN LINE WITH THE IRS CLASSIFICATIONS FOR FORM 990 PURPOSES. THE GLOBAL FUND REGIONAL ALLOCATION IS PROVIDED IN NOTE 3.2 TO ITS AUDITED 2022 ANNUAL FINANCIAL STATEMENTS. |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Idemnification Gross Up Pmts | Yes (X) | IdemnificationGrossUpPmtsInd |
| Written Policy Ref T And E Expnss | Yes (1) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (1) | SubstantiationRequiredInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (1) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (26 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MARK ELDON EDINGTON | ||||||||||||||
| HEAD, GRANT MANAGEMENT DIVISION | $308,228 | $0 | $0 | $0 | $177,144 | $0 | $58,910 | $0 | $4,898 | $0 | $549,180 | $0 | $0 | $0 |
| MARASI MWENCHA | ||||||||||||||
| SENIOR MANAGER, SUPPLY CHAIN | $198,996 | $0 | $0 | $0 | $263,692 | $0 | $36,072 | $0 | $8,360 | $0 | $507,120 | $0 | $0 | $0 |
| PETER ALEXANDER SANDS | ||||||||||||||
| EXECUTIVE DIRECTOR | $408,266 | $0 | $0 | $0 | $2,577 | $0 | $80,248 | $0 | $15,550 | $0 | $506,641 | $0 | $0 | $0 |
| MARIA PETROVA KIROVA | ||||||||||||||
| HEAD, GRANT MANAGEMENT DEPARTMENT | $260,433 | $0 | $0 | $0 | $177,830 | $0 | $48,715 | $0 | $14,046 | $0 | $501,024 | $0 | $0 | $0 |
| MICHAEL WAINFORD JOHNSON | ||||||||||||||
| CHIEF INFORMATION OFFICER | $263,453 | $0 | $0 | $0 | $152,175 | $0 | $49,359 | $0 | $14,609 | $0 | $479,596 | $0 | $0 | $0 |
| GEORGE SHAKARISHVILI | ||||||||||||||
| SENIOR MANAGER, STRATEGY | $77,875 | $0 | $0 | $0 | $372,378 | $0 | $14,015 | $0 | $4,037 | $0 | $468,305 | $0 | $0 | $0 |
| TRACY STAINES | ||||||||||||||
| INSPECTOR GENERAL | $343,376 | $0 | $0 | $0 | $36,217 | $0 | $66,407 | $0 | $9,067 | $0 | $455,067 | $0 | $0 | $0 |
| ABIGAIL MORELAND | ||||||||||||||
| HEAD, GRANT MANAGEMENT DEPARTMENT | $256,206 | $0 | $0 | $0 | $136,655 | $0 | $47,814 | $0 | $14,026 | $0 | $454,701 | $0 | $0 | $0 |
| MICHAEL DAVID BYRNE | ||||||||||||||
| HEAD, TECH ADVISORY & PARTNERSHIPS | $247,147 | $0 | $0 | $0 | $149,560 | $0 | $45,882 | $0 | $11,983 | $0 | $454,572 | $0 | $0 | $0 |
| HARLEY FELDBAUM | ||||||||||||||
| HEAD STRATEGY AND POLICY HUB | $244,221 | $0 | $0 | $0 | $142,941 | $0 | $45,258 | $0 | $11,968 | $0 | $444,388 | $0 | $0 | $0 |
| RAHUL SINGHAL | ||||||||||||||
| CHIEF RISK OFFICER | $292,005 | $0 | $0 | $0 | $82,482 | $0 | $55,450 | $0 | $8,205 | $0 | $438,142 | $0 | $0 | $0 |
| ADDA FAYE | ||||||||||||||
| CHIEF FINANCIAL OFFICER | $292,005 | $0 | $0 | $0 | $67,227 | $0 | $55,450 | $0 | $23,393 | $0 | $438,075 | $0 | $0 | $0 |
| FRANCOISE VANNI CHACIN SOLANO | ||||||||||||||
| HEAD, EXTERNAL RELATIONS AND COMMS | $292,005 | $0 | $0 | $0 | $63,496 | $0 | $55,450 | $0 | $12,203 | $0 | $423,154 | $0 | $0 | $0 |
| SUSIE RHEE | ||||||||||||||
| GENERAL COUNSEL | $229,774 | $0 | $0 | $0 | $123,721 | $0 | $42,328 | $0 | $9,899 | $0 | $405,722 | $0 | $0 | $0 |
| SCOTT JAY FILLER | ||||||||||||||
| HEAD, MALARIA DISEASE ADVISOR | $207,648 | $0 | $0 | $0 | $146,830 | $0 | $37,815 | $0 | $11,789 | $0 | $404,082 | $0 | $0 | $0 |
| NOAH AMADOR ZAHROBSKY | ||||||||||||||
| SENIOR FUND PORTFOLIO MANAGER | $176,361 | $0 | $0 | $0 | $173,693 | $0 | $31,513 | $0 | $13,635 | $0 | $395,202 | $0 | $0 | $0 |
| JOHN ANDREW FAIRHURST | ||||||||||||||
| HEAD, PRIVATE SECTOR ENGAGEMENTS | $246,988 | $0 | $0 | $0 | $79,494 | $0 | $45,847 | $0 | $11,982 | $0 | $384,311 | $0 | $0 | $0 |
| ANNELISE HIRSCHMANN | ||||||||||||||
| HEAD, GRANT MANAGEMENT DEPARTMENT | $229,096 | $0 | $0 | $0 | $91,356 | $0 | $42,136 | $0 | $4,510 | $0 | $367,098 | $0 | $0 | $0 |
| MARIJKE WIJNROKS | ||||||||||||||
| CHIEF OF STAFF | $263,970 | $0 | $0 | $0 | $42,445 | $0 | $49,470 | $0 | $8,068 | $0 | $363,953 | $0 | $0 | $0 |
| URBAN JOHANNES WEBER | ||||||||||||||
| HEAD, GRANT MANAGEMENT DEPARTMENT | $262,482 | $0 | $0 | $0 | $16,830 | $0 | $49,152 | $0 | $8,061 | $0 | $336,525 | $0 | $0 | $0 |
| CATY FALL | ||||||||||||||
| REGIONAL MANAGER, CENTRAL AFRICA | $213,984 | $0 | $0 | $0 | $45,089 | $0 | $39,092 | $0 | $26,732 | $0 | $324,897 | $0 | $0 | $0 |
| HUI YANG | ||||||||||||||
| CHIEF PROCUREMENT OFFICER | $259,560 | $0 | $0 | $0 | $8,760 | $0 | $48,529 | $0 | $4,659 | $0 | $321,508 | $0 | $0 | $0 |
| LINDEN RIDLEY MORRISON | ||||||||||||||
| HEAD, GRANT MANAGEMENT DEPARTMENT | $247,629 | $0 | $0 | $0 | $13,463 | $0 | $45,984 | $0 | $4,601 | $0 | $311,677 | $0 | $0 | $0 |
| CYNTHIA SIMANGELA MWASE | ||||||||||||||
| HEAD, GRANT MANAGEMENT DEPARTMENT | $231,869 | $0 | $0 | $0 | $13,835 | $0 | $42,694 | $0 | $13,838 | $0 | $302,236 | $0 | $0 | $0 |
| MARK EDWARD SAALFELD | ||||||||||||||
| FORMER KEY EMPLOYEE | $176,361 | $0 | $0 | $0 | $75,865 | $0 | $31,513 | $0 | $9,050 | $0 | $292,789 | $0 | $0 | $0 |
| FADY ZEIDAN | ||||||||||||||
| FORMER KEY EMPLOYEE | $159,521 | $0 | $0 | $0 | $65,384 | $0 | $30,608 | $0 | $2,475 | $0 | $257,988 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 1A | NINE KEY EMPLOYEES, FOUR HIGHLY COMPENSATED EMPLOYEES, AND ONE FORMER KEY EMPLOYEE LISTED ON FORM 990, PART VII, RECEIVED TAX GROSS UP PAYMENTS IN 2022. THESE PAYMENTS ARE INCLUDED IN REPORTABLE COMPENSATION FOR THE INDIVIDUALS. |
| PART I, LINE 4A | GEORGE SHAKARISHVILI RECEIVED A SEVERANCE PAYMENT. THE AMOUNT IS INCLUDED IN OTHER REPORTABLE COMPENSATION ON SCHEDULE J, PART II. |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (17 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART I, LINE 5 & PART V, LINES 1A & 2A: | THE REPORTING ORGANIZATION IS A FOREIGN ENTITY OPERATING OUTSIDE THE UNITED STATES AND THEREFORE DOES NOT HAVE A REQUIREMENT TO FILE FORM W-3 OR FORM 1096 TO REPORT EMPLOYEE OR INDEPENDENT CONTRACTOR COMPENSATION. THE GLOBAL FUND EMPLOYED 1,075 INDIVIDUALS ON DECEMBER 31, 2022. |
| FORM 990, ITEM M, LEGAL DOMICILE: | SZ SWITZERLAND |
| FORM 990, ITEM K, OTHER FORM OF ORGANIZATION: | RECOGNIZED AS AN INTERNATIONAL ORGANIZATION UNDER THE INTERNATIONAL ORGANIZATIONS IMMUNITIES ACT (22 U.S. CODE SECTION 288 ET SEQ), THE HEADQUARTERS AGREEMENT WITH THE SWISS FEDERAL COUNCIL AND THE AGREEMENT ON THE PRIVILEGES AND IMMUNITIES OF THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA. |
| FORM 990, PART VI, LINE 20: | THE GLOBAL FUND PHONE NUMBER IS 41-58-791-1700. DUE TO IRS CHARACTER LIMITATIONS AND THE REQUIRED ELECTRONIC FILING OF FORM 990, A TRUNCATED PHONE NUMBER IS PRESENTED ON THIS LINE. |
| FORM 990, PART VI, SECTION A, LINE 4 | THE BYLAWS, BOARD AND COMMITTEE OPERATING PROCEDURES AND BOARD CHAIR AND VICE-CHAIR TERMS OF REFERENCE WERE AMENDED 12 MAY 2022 TO REFLECT THAT THE BOARD LEADERSHIP WILL SERVE THREE-YEAR TERMS INSTEAD OF TWO-YEAR TERMS. THE CHARTERS OF EACH OF THE STANDING COMMITTEES OF THE BOARD WERE ALSO AMENDED 12 MAY 2022 TO REFLECT RECOMMENDATIONS FROM THE GOVERNANCE ACTION PLAN 2.0. THE KEY AMENDMENTS REFLECT THE FOLLOWING: (I) CLARIFICATION OF THE AUDIT AND FINANCE COMMITTEE (AFC)'S OVERSIGHT OF THE HOLISTIC GLOBAL FUND RISK PROFILE AS LEAD RISK MANAGEMENT COMMITTEE, WITH THE STRATEGY COMMITTEE AND ETHICS AND GOVERNANCE COMMITTEE TO ADVISE ON SPECIFIC RISKS ALLOCATED TO THEM BASED ON THEIR RESPECTIVE MANDATES; (II) CLARIFICATION OF ROLES ON STRATEGIC PERFORMANCE REPORTING AND BOARD-APPROVED KEY PERFORMANCE INDICATORS (KPIS), WITH THE STRATEGY COMMITTEE ADVISING ON STRATEGY AND GRANT PORTFOLIO-RELATED KPIS, AND THE AFC ON FINANCIAL MANAGEMENT AND PERFORMANCE KPIS; (III) ALIGNMENT OF THE ETHICS AND GOVERNANCE COMMITTEE MANDATE WITH THE EVOLUTION OF THE GOVERNANCE FUNCTION, AND (IV) ALIGNMENT OF ETHICS AND INTEGRITY FUNCTIONS IN LINE WITH AMENDED POLICY AND TERMINOLOGY. THE CHARTER AMENDMENTS ALSO EXTENDED COMMITTEE MEMBERS' TERMS FROM TWO TO THREE YEARS. THE BOARD AND COMMITTEE OPERATING PROCEDURES WERE SUBSEQUENTLY AMENDED ON 14 JUNE 2022. THE KEY AMENDMENTS REFLECT THE EXTENDED COMMITTEE MEMBER TERMS, THE INTEGRITY DUE DILIGENCE PROCESSES REQUIRED TO BE CONDUCTED BY CONSTITUENCIES, INTERIM ARRANGEMENTS FOR COMMITTEE CHAIRS AND VICE-CHAIRS, CONSTITUENCY REPRESENTATION AND ROTATION PRINCIPLES, EXPEDITED DECISION-MAKING CONSULTATIONS FOR URGENT BOARD DECISIONS AND THE CONDUCT OF VIRTUAL MEETINGS. |
| FORM 990, PART VI, SECTION A, LINE 5 | THE GLOBAL FUND IS FULLY COMMITTED TO THE PRINCIPLES OF TRANSPARENCY AND ACCOUNTABILITY. TO FULFILL THIS COMMITMENT, THE GLOBAL FUND WORKS, THROUGH ITS RISK MANAGEMENT AND ASSURANCE PROCESSES, TO EXPOSE IRREGULARITIES AND MISUSE OF RESOURCES. KEY MEASURES ARE DEDICATED TOWARDS PREVENTION BUT WHERE IRREGULARITIES OR MISUSE HAVE MATERIALIZED, ACTION IS TAKEN TO ADDRESS THE UNDERLYING WEAKNESSES AND SEEK RECOVERIES AS APPROPRIATE. THE GLOBAL FUND MAINTAINS A ZERO TOLERANCE APPROACH TO FRAUD AND CORRUPTION AND AIMS TO TAKE SWIFT AND APPROPRIATE ACTION WHEN CASES OF MISUSE OF FUNDS ARE IDENTIFIED. THE GLOBAL FUND WILL CONTINUE TO ENSURE THAT ALL IDENTIFIED IRREGULARITIES ARE COMMUNICATED RESPONSIBLY AND IN A TIMELY MANNER TO THE BOARD AND TO OTHER STAKEHOLDERS. FROM A FINANCIAL STATEMENT PERSPECTIVE, SUCH MISAPPROPRIATION OF ASSETS OR INELIGIBLE EXPENDITURE ARE RECOGNIZED AS GRANTS UNDER RECOVERY FROM PRINCIPAL RECIPIENTS. THESE ARE RECOGNIZED AT NOMINAL VALUE UPON A FORMAL NOTIFICATION TO THE PRINCIPAL RECIPIENT AND SUBJECT TO THE SAME POLICY OF VALUATION, RISK ASSESSMENT AND ASSET IMPAIRMENT AS CONTRIBUTIONS RECOVERABLE FROM DONORS. NOTE 3.2 OF THE AUDITED FINANCIAL STATEMENTS PROVIDE AN OVERVIEW OF GRANTS UNDER RECOVERY AT 31 DEC 2022 - USD 3 MILLION OF GRANTS UNDER RECOVERY BASED ON THE DEMAND LETTERS FORMALLY ISSUED TO PRINCIPAL RECIPIENTS, NET OF APPROPRIATE PROVISION FOR EXPECTED CREDIT LOSSES. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM IS PREPARED BY THE ACCOUNTING MANAGER WITH THE ASSISTANCE OF A US-BASED TAX ADVISOR. INFORMATION REPORTED IS REVIEWED FOR ACCURACY BY RELEVANT FUNCTIONS, INCLUDING BUT NOT LIMITED TO, SENIOR FINANCE MANAGEMENT, EXTERNAL RELATIONS AND COMMUNICATIONS, HUMAN RESOURCES, AND LEGAL AND GOVERNANCE. |
| FORM 990, PART VI, SECTION B, LINE 12C | THE CONFLICT OF INTEREST POLICY APPLIES TO COVERED PARTIES (GOVERNANCE OFFICIALS, THE SECRETARIAT AND OFFICE OF THE INSPECTOR GENERAL, IMPLEMENTERS OF GLOBAL FUND GRANTS AND CONTRACTUAL COUNTERPARTIES) ALL MEMBERS OF THE BOARD, ALTERNATES, MEMBERS OF STANDING COMMITTEES OF THE BOARD, AND MEMBERS OF OTHER GOVERNANCE, ADVISORY (E.G., TECHNICAL REVIEW PANEL) OR ADMINISTRATIVE BODIES OF THE GLOBAL FUND, INCLUDING PROFESSIONAL EMPLOYEES OF THE GLOBAL FUND. COMPLIANCE WITH THE POLICY IS OVERSEEN BY THE BOARD'S STANDING COMMITTEE MANDATED WITH OVERSIGHT ON ETHICS MATTERS. ANY PERCEIVED, POTENTIAL OR AND ACTUAL CONFLICTS OF INTEREST RELATING TO GOVERNANCE OFFICIALS ARE REFERRED TO THE STANDING COMMITTEE MANDATED WITH OVERSIGHT ON ETHICS MATTERS FOR CONSIDERATION. DISCLOSURE DECLARATION OF INTEREST FORMS AND REGISTERS OF PRIVATE INTERESTS ARE MAINTAINED BY THE ETHICS OFFICER AND MADE AVAILABLE FOR INSPECTION BY THE STANDING COMMITTEE MANDATED WITH OVERSIGHT ON ETHICS MATTERS AS DEEMED APPROPRIATE BY THE STANDING COMMITTEE MANDATED WITH OVERSIGHT ON ETHICS MATTERS, BY THE BOARD AND THE OFFICE OF THE INSPECTOR GENERAL. WHEN AN ACTUAL, OR POTENTIAL OR PERCEIVED CONFLICT OF INTEREST OCCURS IN RELATION TO A GOVERNANCE OFFICIAL, THE ETHICS AND GOVERNANCE COMMITTEE DETERMINES IF THERE IS A CONFLICT OF INTEREST, REVIEWS IT, AND DETERMINES ON THE ADVICE OF THE ETHICS OFFICER IF THE INDIVIDUAL(S) INVOLVED SHOULD BE EXCLUDED FROM THE PARTICULAR CONVERSATION OR DECISION-MAKING PROCESS. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE GLOBAL FUND BOARD APPOINTS THE TOP MANAGEMENT OFFICIAL AND A REMUNERATION PACKAGE IS APPROVED BY THE BOARD, AFTER REVIEW AND APPROVAL BY INDEPENDENT PERSONS, COMPARABILITY AND CONTEMPORANEOUS SUBSTANTIATION AND DELIBERATION IN ACCORDANCE WITH THE APPOINTMENT DECISION. FOR ALL OTHER OFFICERS OR KEY EMPLOYEES, REMUNERATION IS DETERMINED BY THE CEO (EXECUTIVE DIRECTOR) IN CONSULTATION WITH THE HEAD OF HUMAN RESOURCES, AND MAY INCLUDE TAX EQUALIZATION AND DEPENDENTS' EDUCATION COSTS FOR EMPLOYEES MOVING TO SWITZERLAND FROM ANOTHER COUNTRY. REPORTABLE COMPENSATION INCLUDES BASE SALARY AND OTHER AMOUNTS BASED ON THE BENEFITS STRUCTURE. THE LAST COMPENSATION AND BENEFIT REVIEW WAS COMPLETED IN FEBRUARY 2020. |
| FORM 990, PART VI, SECTION C, LINE 19 | ALL GOVERNING DOCUMENTS APPROVED BY THE GLOBAL FUND BOARD, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE ON THE GLOBAL FUND'S WEBSITE. |
| FORM 990, PART IX, LINE 24A: | FEES PAID TO LOCAL FUND AGENTS TO ASSESS LOCAL CAPACITY PRIOR TO AND DURING GRANT NEGOTIATION, AND TO MANAGE AND MONITOR IMPLEMENTATION OF FUNDED PROGRAMS AS GRANTS ARE DISBURSED, ARE EXPENSED AS THE WORK IS PERFORMED. |
| FORM 990, PART IX, LINE 11F: | THESE EXPENSES REPRESENT TRUSTEE FEES INCURRED FOR THE MANAGEMENT OF A TRUST FUND AT THE WORLD BANK. |
| FORM 990, PART IX: | MODIFIED IFRS IS USED AS THE METHOD OF ACCOUNTING FOR THE EXPENDITURES. THE MODIFICATION INCLUDES UNREALIZED FOREIGN CURRENCY GAIN OF $26,579,973 ON OPERATING EXPENDITURES, WHICH HAS NOT BEEN NETTED AGAINST OPERATING EXPENDITURES REPORTABLE ON PART IX, STATEMENT OF FUNCTIONAL EXPENSES. SEE NOTE 6.1 TO THE 2022 ANNUAL FINANCIAL STATEMENTS FOR MORE DETAILS ON THE OPERATING EXPENDITURES. |
| FORM 990, PART XI, LINE 9: | NET UNREALIZED FOREIGN EXCHANGE LOSS -328,842,189. PROVIDENT FUND IAS 19 VALUATION ADJUSTMENT 28,435,005. IAS DBO -25,242,240. GRANTS RECOVERED 3,142,583. REIMBURSEMENTS OF PRIOR YEAR SUPPLY EXPENSES 551,151. THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AUDITED IN ACCORDANCE WITH INTERNATIONAL FINANCIAL REPORTING STANDARDS (IFRS). |
| FORM 990, PART XII, LINE 2B: | THE 2022 ANNUAL FINANCIAL STATEMENTS HAVE BEEN AUDITED BY KPMG SA AND APPROVED BY THE BOARD IN APRIL 2023. THESE ARE PUBLISHED ON THE GLOBAL FUND'S PUBLIC WEBSITE. |
| FORM 990, PART XII, LINE 5: | THE GLOBAL FUND DOES NOT HOLD SECURITIES BUT HOLDS A SHARE OF ASSETS IN A TRUST AS PART OF A GREATER POOL OF ASSETS. THE UNDERLYING ASSETS WITHIN THE POOL ARE REPORTED AS FAIR VALUE. SEE NOTES 5.2 AND 5.8 TO THE ANNUAL FINANCIAL STATEMENTS. UNREALIZED GAINS (LOSSES) REPORTED ON FORM 990 IS IN LINE WITH THE GLOBAL FUND'S ANNUAL AUDITED FINANCIAL STATEMENTS. |
| CONVERSION RATE: | THE GLOBAL FUND IS A FOREIGN ORGANIZATION. THE FOLLOWING EXCHANGE RATES WERE USED TO CONVERT THE STATED INFORMATION FROM THE FUNCTIONAL CURRENCY TO THE US DOLLAR. AUSTRALIAN DOLLAR - 0.6814 CANADIAN DOLLAR - 0.7380 SWISS FRANCS - 1.0815 EUROS - 1.0704 POUND STERLING - 1.2098 SWEDISH KRONA - 0.0959 NORWEGIAN KRONE - 0.1021 |